Recombinant human interferon alpha-1b (Changchun Institute of Biological Products)

重组人干扰素α1b滴眼液（长春生物制品研究所有限责任公司）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human interferon alpha-1b (Changchun Institute of Biological Products)
Drug Alias NameChangshengfuming长生扶明
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsEye Infections
Global Approved IndicationsEye Infections
Approved Indications in ChinaEye Infections
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChangchun Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChangchun Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsEye Infections
Inactive IndicationsN/A

Other Information

ATC CodeL03AB
Related LinksN/A